TyraTech, Inc. Appointment of Jos arella as Chairman (7087U)
11 April 2016 - 4:00PM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 7087U
TyraTech, Inc.
11 April 2016
Strictly Embargoed until 07.00: 11 April 2016
TyraTech, Inc.
("TyraTech" or the "Company")
Appointment of José Barella as Chairman
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences technology
company focused on nature-derived insect and parasite control
products, announces the appointment of José Geraldo Ramalho
Barella, aged 60, as Non-Executive Chairman with immediate effect.
Alan Reade will step down as Chairman, but will remain on the Board
as a Non-Executive Director.
Mr Barella, a Brazilian citizen, has significant global
experience across the Animal Health, Human Health, Crop Protection
and Chemical Industries, having held a variety of senior management
and executive positions throughout his career. José holds a BSc in
Chemical Engineering and is fluent in Portuguese, English and
French.
He began his career in 1982 in the chemical industry, first at
steel maker Cosipa and later with Alcoa. Subsequently, he joined
Rhone Poulenc's Brazilian subsidiary Rhodia in 1986 and over a six
year period held several senior positions in engineering, project
management and marketing.
In 1992 he was appointed VP of Industrial Operations for Rhodia
Pharma, the Human Health division of Rhone Poulenc Rorer. Over his
four year tenure the division experienced impressive improvement:
the industrial footprint was re-designed with the closure of a
plant and new supply chain and planning through MRP was implemented
- resulting in a six fold increase in productivity with only
marginal investment. José's use of modern management philosophy has
been highlighted in many articles and books.
In 1995 Mr Barella joined Rhone Poulenc Agro based in Lyon,
France as Global Marketing Manager for herbicides, with
responsibility for manufacturing, development and marketing. In
1997 he moved to London as commercial manager responsible for the
UK and Ireland covering all sales and marketing activities. In 1999
Rhone Poulenc merged with Hoechst to form Aventis and José was
appointed Head of Aventis Environmental Science, based in
Frankfurt, Germany. He integrated all the non-crop assets of the
crop protection divisions.
During his tenure, he developed and oversaw the implementation
of a 10 year strategic plan for the new division including the
divestment of non-strategic assets and the acquisition of a US
consumer business. During this period the division experienced
sales growth of 30% per year reaching over US$ 350 million and EBIT
doubled.
In 2001 José joined Merial, the stand alone Animal Health JV of
Merck and Aventis, based in Atlanta GA, USA to lead the Companion
Animals division. In 2003 he added the role of Head of Global
Supply Chain to his area of responsibility and in 2005 became Chief
Operating Officer with responsibility for Companion and Production
Animals. In 2007 he was appointed CEO of Merial and when in 2011
Merial became the Animal Health Division of Sanofi, José was
appointed Senior VP Animal Health and CEO of Merial.
During his 12 years at the Company, Merial grew sales from
US$1.5 billion to US$2.8 billion. EBIT increased from US$200
million to US$870 million with Frontline one of the most successful
products in the history of Animal Health.
Most recently from April 2013 to December 2015 José joined the
Advisory Board of mABxience, a biotech company based in Madrid,
Spain with a focus in the development, manufacturing and
commercialisation of biosimilars for human health.
In February 2015 he was appointed Chairman of Netafim. Based in
Tel-Aviv, Netafim is a world leader in irrigation with a global
footprint and sales in excess of US$750 million.
Commenting on Mr Barella's appointment Alan Reade, outgoing
Chairman said:
"I have known and worked with José for many years and his
industry knowledge, experience and contacts will be invaluable as
TyraTech continues to commercialise its technology and ramps-up
over the coming years. My intention is to remain with the Company
for a couple of months to help smooth the transition at a very
important stage in our development. I will then step down and
retire, safe in the knowledge that the Board has gained world class
leadership. Consequently I will not be offering myself for
re-election at the Annual General Meeting. I wish José and all the
management team great success over the coming years."
José Barella, Non-executive Chairman added:
"I have been aware of TyraTech for some time. They have
developed world class technology with multiple market commercial
applications. I am honoured to have been appointed as Chairman and
look forward to working with the management team to focus on
exploiting the opportunities afforded to us. Alan has left the
business in a strong position and I wish him a very happy
retirement."
Additional information in relation to José Geraldo Ramalho
Barella:
The following information is disclosed pursuant to Schedule Two
paragraph (g) of the AIM Rules for Companies:
Current Directorships and Partnerships as at the date of this
announcement
NETAFIM Ltd
Directorships held during the past five years
MABxcience S.A.
There are no further disclosures required in accordance with the
AIM Rules in relation to José Barella.
*-ends*-
For further information please visit: www.tyratech.com or
contact:
TyraTech Inc. Tel: +1 919 415 4340
Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4287
Erica H. Boisvert, Chief Financial Officer
SPARK Advisory Partners Limited, Nominated Adviser Tel: +44 203 368 3551
Matt Davis / Mark Brady
Allenby Capital Limited , Joint Broker Tel: +44 20 3328 5656
Chris Crawford
Whitman Howard Limited, Joint Broker Tel: +44 20 7659 1234
Ranald McGregor-Smith
Belvedere Communications (PR) Tel: +44 20 3567 0510
John West / Kim van Beeck
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASSEFWAFMSESL
(END) Dow Jones Newswires
April 11, 2016 02:00 ET (06:00 GMT)
Tyratech (DI) (LSE:TYRU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (DI) (LSE:TYRU)
Historical Stock Chart
From Jul 2023 to Jul 2024